Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial

Victor F. Tapson, Fernando Torres, Fiona Kermeen, Anne M. Keogh, Roblee P Allen, Robert P. Frantz, David B. Badesch, Adaani E. Frost, Shelley M. Shapiro, Kevin Laliberte, Jeffrey Sigman, Carl Arneson, Nazzareno Galiè

Research output: Contribution to journalArticlepeer-review

251 Scopus citations

Fingerprint

Dive into the research topics of 'Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences